American Healthcare REIT, Inc. (AHR) FinancialsAHRAmerican Healthcare REIT, Inc.

American Healthcare REIT, Inc. (AHR) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Private and other payors, accounting for 49.1% of total sales, equivalent to $311.65M. Other significant revenue streams include Medicare and Medicaid. Understanding this composition is critical for investors evaluating how AHR navigates market cycles within the Specialized REITs industry.

Evaluating the bottom line, American Healthcare REIT, Inc. maintains a gross margin of 18.48%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 6.71%, while the net margin is 4.59%. These profitability ratios, combined with a Return on Equity (ROE) of 3.96%, provide a clear picture of how effectively AHR converts its operational activities into shareholder value.

In the context of the broader market, AHR competes directly with industry leaders such as GLPI and ELS. With a market capitalization of $12.15B, it holds a leading position in the sector. When comparing efficiency, AHR's gross margin of 18.48% stands against GLPI's 97.45% and ELS's 38.42%. Such benchmarking helps identify whether American Healthcare REIT, Inc. is trading at a premium or discount relative to its financial performance.

American Healthcare REIT has demonstrated solid financial performance, with total revenue increasing from $542 million in Q2 2025 to $674 million in Q2 2026, and net income rising from $9.9 million in Q2 2025 to $30.6 million in Q2 2026, showing a positive trend in profitability.